We are a specialty performance chemical company with a legacy of over four decades, engaged in the business of manufacturing specialty performance chemicals with a diverse portfolio of over 350 customized formulations across four primary product segments such as (i) Polymers, (ii) Surfactants, ... Read more
| Investors Category | Shares Offered |
|---|---|
| Anchor Investors | 13,06,800 (28.48%) |
| Market Makers | 2,32,800 (5.07%) |
| Non Institutional Investors | 6,53,400 (14.24%) |
| Qualified Institutional Buyers (QIBs) | 8,71,200 (18.99%) |
| Retail Individual Investors (RIIs) | 15,24,600 (33.22%) |
| Year End | Revenue | PAT | Reserves & Surplus |
|---|---|---|---|
| 31 Mar 2024 | 62.01 Cr | 1.93 Cr | 5.64 Cr |
| 31 Mar 2023 | 48.79 Cr | 1.14 Cr | 2.96 Cr |
| 31 Mar 2022 | 48.69 Cr | 97.13 Lakh | 1.09 Cr |
1. Funding the long-term working capital requirements of the Company
2. Repayment/prepayment, in full or part, of all or certain outstanding borrowings availed by our Company
3. General Corporate Purposes
| Pricing Details | BSE | NSE |
|---|---|---|
| Issue Price | - | ₹ 98.00 |
| Open | - | ₹ 108.00 |
| Low | - | ₹ 102.60 |
| High | - | ₹ 113.40 |
| Last Trade | - | ₹ 111.80 |
The global chemicals industry was valued at approximately $5.7 trillion in 2023, contributing around 7% to global GDP. The industry is estimated to have been valued at $5.9 trillion in 2024. The industry has grown at a CAGR of 7% from 2014 to 2024 and is projected to grow at 7%, reaching nearly ... Read more
When does Neochem Bio Solutions Ltd. IPO opens and closes?
What is the size of Neochem Bio Solutions Ltd. IPO?
What is the price range of Neochem Bio Solutions Ltd. IPO?
What is the minimum investment and lot size required for the Neochem Bio Solutions Ltd. IPO?
When is Neochem Bio Solutions Ltd. IPO listing date?
What is the objective of Neochem Bio Solutions Ltd. IPO?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article